Described herein is a diamond and diamond products comprising:
a NV0 or SiV0 defect, wherein the NV0 or SiV0 defect comprises a nitrogen atom or silicon atom replacing a carbon atom in the diamond and a neutral vacancy replacing a carbon atom adjacent to the nitrogen atom or silicon atom in the diamond;
a NV− or SiV− defect, wherein the NV− or SiV− defect comprises a nitrogen atom or silicon atom replacing a carbon atom in the diamond and a negatively-charged vacancy replacing a carbon atom adjacent to the nitrogen atom or silicon atom in the diamond; and
a halide atom.
Described herein are targeting moieties that can be capable of specifically targeting muscle cells and can include an n-mer motif. In some embodiments, the n-mer motif contains an RGD motif. Also described herein are vector systems, particles, polypeptides that can encode and/or contain one or more targeting moieties. Also described herein are methods of delivering a cargo to a cell, such as a muscle cell, using one or more of the targeting moieties described herein.
A61K 31/7088 - Composés ayant au moins trois nucléosides ou nucléotides
A61K 47/64 - Conjugués médicament-peptide, médicament-protéine ou médicament-acide polyaminé, c.-à-d. l’agent de modification étant un peptide, une protéine ou un acide polyaminé lié par covalence ou complexé à un agent thérapeutiquement actif
A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiquesThérapie génique
C07K 7/06 - Peptides linéaires ne contenant que des liaisons peptidiques normales ayant de 5 à 11 amino-acides
C07K 14/005 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de virus
C07K 14/47 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères
B82Y 15/00 - Nanotechnologie pour l’interaction, la détection ou l'actionnement, p. ex. points quantiques comme marqueurs en dosages protéiques ou moteurs moléculaires
G01N 27/22 - Recherche ou analyse des matériaux par l'emploi de moyens électriques, électrochimiques ou magnétiques en recherchant l'impédance en recherchant la capacité
The present disclosure provides compositions which enable the delivery of cargo, including therapeutic agents such as RNA, to organs or tissues in addition to the liver, lungs, and spleen, such as brain, heart, kidney, and muscle tissue. More specifically, the compositions comprise a plurality of lipid particles comprising an agent, cationic lipids and ionizable lipid.
A61K 9/127 - Vecteurs à bicouches synthétiques, p. ex. liposomes ou liposomes comportant du cholestérol en tant qu’unique agent tensioactif non phosphatidylique
Microstructures, their use, and methods for making microstructures are provided, where the methods involve applying an external stimulus to a plurality of packed, polymeric microspheres, wherein the polymeric microspheres have a porosity of between about 20% to 99%, and wherein at least a boundary layer of the polymeric microspheres are in contact with a surface; such that the polymeric microspheres collapse into smaller and denser microspheres that join with adjacent microspheres at contact points to form a micronetwork, wherein the contact points comprise microstructures extruded from the polymeric microspheres.
B01J 13/02 - Fabrication de microcapsules ou de microbilles
B29C 43/00 - Moulage par pressage, c.-à-d. en appliquant une pression externe pour faire couler la matière à moulerAppareils à cet effet
C07K 14/435 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
G01N 33/543 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet avec un support insoluble pour l'immobilisation de composés immunochimiques
SYNTHESIS OF ESTER, CARBONATE, AND CARBAMATE-DERIVED NOVEL BIODEGRADABLE IONIZABLE LIPIDS FROM METHYL RICINOLEATE OR METHYL 12-HYDROXYSTEARATE AND ITS APPLICATIONS
Provided herein are compounds, such as compounds of Formula (I), and pharmaceutically acceptable salts, hydrates, solvates, polymorphs, co-crystals, tautomers, stereoisomers, and isotopically labeled derivatives thereof, and compositions, methods, uses, and kits thereof. The compounds provided herein are lipids useful for delivery of polynucleotides, such as mRNA, for the treatment and/or prevention of various diseases and conditions (e.g., genetic disease, proliferative disease, hematological disease, neurological disease, liver disease, spleen disease, lung disease, painful condition, psychiatric disorder, musculoskeletal disease, a metabolic disorder, inflammatory disease, or autoimmune disease).
A61K 9/127 - Vecteurs à bicouches synthétiques, p. ex. liposomes ou liposomes comportant du cholestérol en tant qu’unique agent tensioactif non phosphatidylique
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 31/7105 - Acides ribonucléiques naturels, c.-à-d. contenant uniquement des riboses liés à l'adénine, la guanine, la cytosine ou l'uracile et ayant des liaisons 3'-5' phosphodiester
A61K 31/711 - Acides désoxyribonucléiques naturels, c.-à-d. contenant uniquement des 2'-désoxyriboses liés à l'adénine, la guanine, la cytosine ou la thymine et ayant des liaisons 3'-5' phosphodiester
C07C 229/12 - Composés contenant des groupes amino et carboxyle liés au même squelette carboné ayant des groupes amino et carboxyle liés à des atomes de carbone acycliques du même squelette carboné le squelette carboné étant acyclique et saturé ayant un seul groupe amino et un seul groupe carboxyle liés au squelette carboné l'atome d'azote du groupe amino étant lié de plus à des atomes de carbone acycliques ou à des atomes de carbone de cycles autres que des cycles aromatiques à six chaînons à des atomes de carbone de squelettes carbonés acycliques
C07C 229/16 - Composés contenant des groupes amino et carboxyle liés au même squelette carboné ayant des groupes amino et carboxyle liés à des atomes de carbone acycliques du même squelette carboné le squelette carboné étant acyclique et saturé ayant un seul groupe amino et un seul groupe carboxyle liés au squelette carboné l'atome d'azote du groupe amino étant lié de plus à des atomes de carbone acycliques ou à des atomes de carbone de cycles autres que des cycles aromatiques à six chaînons à des atomes de carbone de radicaux hydrocarbonés substitués par des groupes amino ou carboxyle, p. ex. acide éthylènediaminetétra-acétique, acides iminodiacétiques
C07D 207/06 - Composés hétérocycliques contenant des cycles à cinq chaînons, non condensés avec d'autres cycles, ne comportant qu'un atome d'azote comme unique hétéro-atome du cycle avec uniquement des atomes d'hydrogène ou de carbone liés directement à l'atome d'azote du cycle ne comportant pas de liaison double entre chaînons cycliques ou entre chaînons cycliques et chaînons non cycliques avec des radicaux contenant uniquement des atomes d'hydrogène et de carbone, liés aux atomes de carbone du cycle
C07D 213/38 - Radicaux substitués par des atomes d'azote liés par des liaisons simples comportant uniquement de l'hydrogène, ou des radicaux hydrocarbonés, liés à l'atome d'azote substituant
C07D 255/02 - Composés hétérocycliques contenant des cycles comportant trois atomes d'azote comme uniques hétéro-atomes du cycle, non prévus par les groupes non condensés avec d'autres cycles
C07D 295/13 - Composés hétérocycliques contenant des cycles polyméthylène imine d'au moins cinq chaînons, des cycles aza-3 bicyclo [3.2.2] nonane, piperazine, morpholine ou thiomorpholine, ne comportant que des atomes d'hydrogène liés directement aux atomes de carbone du cycle avec des radicaux hydrocarbonés substitués liés aux atomes d'azote du cycle substitués par des atomes d'azote liés par des liaisons simples ou doubles avec les atomes d'azote du cycle et les atomes d'azote substituants liés à la même chaîne carbonée, qui n'est pas interrompue par des cycles carbocycliques à une chaîne acyclique saturée
C12N 15/88 - Introduction de matériel génétique étranger utilisant des procédés non prévus ailleurs, p. ex. co-transformation utilisant la micro-encapsulation, p. ex. utilisant des vésicules liposomiques
7.
Methods and Apparatus for Imaging with Conformable Ultrasound Patch
An ultrasound patch may conform to a curved surface of a large, curvilinear part of a human body, and may capture ultrasound images of underlying tissue for detection of disease. The patch may comprise a flexible, elastomeric substrate, in which phased arrays of piezoelectric ultrasound transducers are embedded. The phased arrays may steer ultrasound beams through a wide angle to image a large volume of tissue. Mechanical deformation of the flexible substrate as it conforms to a curvilinear body part may change the relative 3D positions of the phase arrays. However, localization may be performed to detect these 3D positions. Data captured by the phased arrays may be processed, to create an ultrasound image of the underlying tissue. A semi-flexible, intermediate layer may partially encapsulate each phased array, to distribute stress at an interface between the rigid phased array and more flexible substrate.
The use of elongated nanostructures in separators and associated devices and methods, including devices and methods for energy storage and/or use, are generally described. According to certain embodiments, the elongated nanostructures can extend from a first solid substrate to a second solid substrate. In some embodiments, the nanostructures penetrate a surface of the first solid substrate (e.g., a first electrode) and/or a surface of the second solid substrate (e.g., a second electrode). The elongated nanostructures can, according to certain embodiments, provide structural reinforcement between two substrates (e.g., between two electrodes) while maintaining electronic insulation between the two substrates.
A clutch device includes two pluralities of flexible members interleaved with each other. An overlapping region is defined where the flexible members overlap each other. Non-overlapping regions are on opposing sides of the overlapping region. The non-overlapping regions are regions in which the flexible members do not overlap each other. In a locked arrangement, an outer portion of each non-overlapping region extends at a first angle relative to the overlapping region. The first angle causes the flexible members to engage and interlock with each other. The outer portions of can be moved to a second angle different than the first angle to unlock the clutch device and allow the flexible members to disengage with and be separated from each other. The clutch device thus does not require continuous energy input while also having a high locking force that can be rapidly applied or released.
B25J 19/00 - Accessoires adaptés aux manipulateurs, p. ex. pour contrôler, pour observerDispositifs de sécurité combinés avec les manipulateurs ou spécialement conçus pour être utilisés en association avec ces manipulateurs
Systems, devices, and methods for the detection of analytes such as per- and polyfluoroalkyl substances (PFAS) in samples are generally described. Certain aspects of the present disclosure are related to systems for detecting analytes in samples. In some embodiments, a cartridge is used that comprises a plurality of microwells. The microwells can comprise, for example, a chamber and an optional cutout section. In some embodiments, the microwell has a volume of 0.001-1,000 pl (e.g., 0.1-100 pl), which can, for example, provide sufficient volume to detect the present of PFAS while also not being so large as to require a long amount of time before producing a result. In certain embodiments, the cartridge comprises a layer domain, which can hermetically seal the microwells. The layer domain can be, in some embodiments, configured to reseal after insertion of a needle.
G01N 9/24 - Recherche du poids spécifique ou de la densité des matériauxAnalyse des matériaux en déterminant le poids spécifique ou la densité en observant la propagation de l'onde ou de la radiation des particules à travers le matériau
G01N 15/10 - Recherche de particules individuelles
G01N 15/14 - Techniques de recherche optique, p. ex. cytométrie en flux
12.
SINGLE-CELL DENSITY AS A BIOMARKER FOR DRUG SENSITIVITY
G01N 15/14 - Techniques de recherche optique, p. ex. cytométrie en flux
G01N 9/24 - Recherche du poids spécifique ou de la densité des matériauxAnalyse des matériaux en déterminant le poids spécifique ou la densité en observant la propagation de l'onde ou de la radiation des particules à travers le matériau
G01N 15/10 - Recherche de particules individuelles
13.
PARTITIONED CABLE JOINT FOR SUPERCONDUCTING CABLES
Described is a partitioned cable joint comprising a plurality of physically distributed joint elements with the plurality of joint elements taken together defining a joint length. Joint elements may have a first mounting region having a shape selected to accept one petal of superconducting cable and a second mounting region having a shape selected to accept one petal of a second conductor.
Disclosed herein are methods and systems utilizing CRISPR effector systems for assays and diagnostics. Embodiments herein provide tile probes in systems and methods for detection of multiple targets across a given genome or group of genomes, including in circulating nucleic acid samples.
C12Q 1/689 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les bactéries
C12Q 1/6818 - Tests d’hybridation caractérisés par les moyens de détection impliquant l’interaction de plusieurs marqueurs, p. ex. transfert d’énergie de résonance
One or more unit-test cases are generated from a monolingual code corpus and the generated unit-test cases are filtered to generate a corpus of unit-test cases which have acceptability scores exceeding one or more predefined thresholds. One or more of the code samples of the monolingual code corpus are translated from a source language to a target language using a pretrained Large Language Model and the generated unit-test cases are translated from the source language to the target language. The LLM-translated code samples are validated using the translated unit-test cases and a parallel-data training corpus comprising the LLM-translated code samples that pass the validation is created. The pretrained large language model (LLM) is fine-tuned using the parallel-data training corpus, a given code segment is translated using the fine-tuned large language model (LLM), the translated given code segment is tested and the tested given code segment is deployed.
Provided herein are processes for preparing an oligomer (e.g., a morpholino oligomer). The synthetic processes described herein may be advantageous to scaling up oligomersynthesis while maintaining overall yield and purity of a synthesized oligomer.
Mammals rely on adaptive immunity to protect against infections and tumors, with the thymus playing a crucial role by producing T cells that target infected or cancerous cells. The thymus, however, undergoes functional decline with age, significantly impairing the immune system in the elderly. To investigate reversing this decline, compositions and methods for activation and differentiation of T cell progenitors in extrathymic tissues are disclosed that stimulate production of differentiated T cells. For example, LNP-mediated delivery of mRNAs encoding DLL-1, IL-7, and FLT3L to the liver is shown to create a temporary site for T cell maturation that enhances T cell-mediated immunity in aged mice without causing autoimmunity. This approach facilitates ectopic T cell development from hematopoietic precursors and activates dendritic cells, providing evidence that engineering adaptive immunity in vivo can effectively mitigate immune aging.
A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiquesThérapie génique
Described herein are muscle-specific targeting moieties and compositions including the muscle specific targeting motifs. Also described herein are uses of the muscle-specific targeting motifs and compositions including the muscle specific targeting moieties. In some embodiments, the muscle-specific targeting moieties and compositions including the muscle specific targeting moieties can be used to direct delivery of a cargo to a muscle cell.
A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiquesThérapie génique
A61P 21/00 - Médicaments pour le traitement des troubles du système musculaire ou neuromusculaire
19.
ADVANCEMENTS IN MAGNETOMICROMETRY, STATE-ESTIMATION AND NEUROMUSCULAR CONTROL
Systems, devices, or methods described herein may involve a human augmentation device configured to estimate the state of at least one implanted magnetic target. In some example embodiments, the device may comprise an array of sensors configured to measure one or more target field characteristics. In some example embodiments, the device may comprise a processing element configured to acquire measurements of the one or more target field characteristics and apply information-theoretic processing of the measurements to estimate in real-time the state and error covariance of at least one target state vector. In some example embodiments, the device may comprise a processing element configured to control an actuator of the human augmentation device.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61F 2/72 - Commandes bioélectriques, p. ex. myoélectriques
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
20.
OBJECT FABRICATION AND TRACKING WITH EMBEDDED FLUORESCENT MARKERS
An object includes an object body formed from a build material and a marker embedded in a part of the object body. The marker is formed from a fluorescent marker material configured to emit radiation with a first wavelength when exposed to radiation with a second wavelength. The build material in the part of the object body is translucent to radiation with the first wavelength and the second wavelength.
G06K 7/12 - Méthodes ou dispositions pour la lecture de supports d'enregistrement par radiation électromagnétique, p. ex. lecture optiqueMéthodes ou dispositions pour la lecture de supports d'enregistrement par radiation corpusculaire utilisant une longueur d'onde choisie, p. ex. pour lire des marques rouges et ignorer des marques bleues
G01N 33/58 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des substances marquées
H04N 23/68 - Commande des caméras ou des modules de caméras pour une prise de vue stable de la scène, p. ex. en compensant les vibrations du boîtier de l'appareil photo
21.
NON-CANONICAL CELL-PENETRATING PEPTIDES FOR ANTISENSE OLIGOMER DELIVERY
Provided herein are antisense oligomer conjugates. In one embodiment, the antisense oligomer conjugates comprise a phosphorodiamidate morpholino oligomer (PMO) which is covalently linked to a cell-penetrating peptide (CPP). Also provided herein are methods of treating a muscle disease, such as Duchenne muscular dystrophy, a viral infection, or a bacterial infection in a subject in need thereof, comprising administering to the subject one or more of the antisense oligomer conjugates described herein.
A61K 47/64 - Conjugués médicament-peptide, médicament-protéine ou médicament-acide polyaminé, c.-à-d. l’agent de modification étant un peptide, une protéine ou un acide polyaminé lié par covalence ou complexé à un agent thérapeutiquement actif
A61P 21/00 - Médicaments pour le traitement des troubles du système musculaire ou neuromusculaire
41 - Éducation, divertissements, activités sportives et culturelles
Produits et services
Educational services, namely, providing science educational mentoring services and programs; providing educational demonstrations; providing training and mentorship in the fields of innovation, product design, product development, scientific research, entrepreneurship, problem solving, and business; developing curriculum for educators; organization of exhibitions for cultural or educational purposes; providing information relating to educational and entertainment activities and events for children; educational services, namely, providing a learning and innovation center featuring fully customized leadership, motivational, educational, and brainstorming training; providing information relating to education services; providing courses of instruction at the kindergarten level; providing courses of instruction at the primary level; providing courses of instruction at the high school level; providing courses of instruction at the undergraduate level; providing courses of instruction at the post-graduate level; educational services, namely, developing, arranging, and conducting educational conferences and programs in the fields of innovation, product design, product development, scientific research, entrepreneurship, problem solving, and business; educational services, namely, providing classes and workshops in the fields of innovation, product design, product development, scientific research, entrepreneurship, problem solving, and business; arranging and conducting educational competitions for students in the fields of science, innovation, product design, product development, and business
23.
SYSTEMS AND METHODS FOR SEPARATION OF CARBON DIOXIDE
Polyamines are water-soluble polyelectrolytes with the amino groups that can be used to attach the polymers onto functional surfaces of fibrous materials. In addition, polyamines can be readily modified by (super)nucleophilic groups such as (alkyl)aminopyridines that enhance the polymer's ability to promote hydrolysis of organophosphorous chemical warfare agents. Furthermore, attachment of hydantoin moieties augments the number of the imide, amide, or amine groups groups on the polyamine's chain, which provides oxidizing properties to the resulting modified polyamine after halogenation. In one aspect, disclosed herein are polyamines with side chains modified to contain both (4-aminopyridine, APy) and 5-(4-hydroxybenzylidene)hydantoin (HBH) functionalities with enhanced content of the active bromine. Viricidal activity of the APy- and HBH-modified polyallylamine against human coronavirus (type 229E) was tested both in solution and on nylon-cotton fabric. The polymers are effective at inactivating the coronavirus, at both low concentrations and short exposure times.
A01P 1/00 - DésinfectantsComposés antimicrobiens ou leurs mélanges
C08F 226/06 - Copolymères de composés contenant un ou plusieurs radicaux aliphatiques non saturés, chaque radical ne contenant qu'une seule liaison double carbone-carbone et l'un au moins étant terminé par une liaison simple ou double à l'azote ou par un hétérocycle contenant de l'azote par un hétérocycle contenant de l'azote
25.
CONFORMABLE ULTRASOUND SCANNING AND IMAGING METHODS AND APPARATUS AND RELATED TECHNIQUES
Described herein is a patch, comprising: a honeycomb structure comprised of two or more cells, wherein each of the two or more cells include a window and one or more first attachment means; and a tracker comprised of a sensor and one or more second attachment means configured to mate with the first attachment means to arrange the sensor in the window, wherein the tracker is moved to different ones of the cells to traverse a path along the patch. In some embodiments, the two or more cells have a regular or irregular shape. In embodiments, there are two or more first attachment means and two or more second attachment means that mate to form a first position and a second position, wherein the tracker is configured move between the first position and the second position.
A multistage water treatment system that requires minimum energy and can be powered by low-grade energy sources, such as sunlight, is disclosed. The system may include multiple stages, where each stage comprises a hydrophobic membrane, a confined saline layer, and a condenser. Using a saline layer as the evaporator, as confined by a hydrophobic membrane, strong thermohaline convection is initiated to mitigate salt accumulation and enhance heat transfer. The multistage water treatment system is salt-resistant during continuous desalination of nearly saturated saline. Such a system enables water treatment by low-grade heat with water production exceeding the single-stage limit and ultrahigh salinity. This system is useful for water treatment, including seawater desalination, wastewater reclamation, residential water softening, and salt production from brine/seawater.
THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (USA)
TRUSTEES OF DARTMOUTH COLLEGE (USA)
MASSACHUSETTS INSTITUTE OF TECHNOLOGY (USA)
Inventeur(s)
Strey, Lilianne R.
Strey, Helmut
Granger, Richard M.
Edelman, Alan
Rackauckas, Christopher
Miller, Earl K.
Abrégé
A system for generation and execution of brain circuit simulators includes at least one modular, hierarchical design comprising a plurality of micro-circuits. The system includes a neural control circuit simulator executing a simulation of the at least one design. The system includes a user interface comprising at least one interface element for manipulating output of the neural control circuit simulator. A method includes receiving, by a neural control circuit simulator, an identification of at least one modular, hierarchical design comprising a plurality of micro-circuits, the at least one modular, hierarchical design generated by a first user. The neural control circuit simulator executes a first simulation of the at least one design, using a first data set as simulation input. The neural control circuit simulator receives a second data set and executes a second simulation of the at least one modular, hierarchical design, using the second data set as simulation input.
G06N 3/10 - Interfaces, langages de programmation ou boîtes à outils de développement logiciel, p. ex. pour la simulation de réseaux neuronaux
G06N 3/063 - Réalisation physique, c.-à-d. mise en œuvre matérielle de réseaux neuronaux, de neurones ou de parties de neurone utilisant des moyens électroniques
28.
SCALABLE PROCESS FOR MANUFACTURING TRIFLUOROSULFONAMIDES
FAN1FAN1 derived from the pre-mRNA in a target cell. The compositions and methods are particularly suited for treating, ameliorating, or delaying the onset of a trinucleotide repeat expansion disorder in a subject in need thereof.
C12N 15/113 - Acides nucléiques non codants modulant l'expression des gènes, p. ex. oligonucléotides anti-sens
A61K 31/712 - Acides nucléiques ou oligonucléotides ayant des sucres modifiés, c.-à-d. autres que le ribose ou le 2'-désoxyribose
A61K 31/7125 - Acides nucléiques ou oligonucléotides ayant des liaisons internucléosides modifiées, c.-à-d. autres que des liaisons 3'-5' phosphodiester
C12N 9/16 - Hydrolases (3.) agissant sur les liaisons esters (3.1)
C12N 15/67 - Méthodes générales pour favoriser l'expression
30.
COMPOSITIONS AND METHODS FOR TREATING FAN1 ASSOCIATED TRINUCLEOTIDE REPEAT EXPANSION DISORDERS
Compositions and methods thereof for increasing endogenous FAN1 expression in a target cell are provided. Preferably, compositions include one or more splice switching antisense oligonucleotides targeting FAN1 exon 10-intron 10-exon 11 junction. The compositions are effective in increasing levels of functional FAN1 mRNA transcripts encoding FAN1 derived from the pre-mRNA in a target cell. The compositions and methods are particularly suited for treating, ameliorating, or delaying the onset of a trinucleotide repeat expansion disorder in a subject in need thereof.
A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiquesThérapie génique
Insulin therapy revolutionized the care of patients with diabetes, yet insulin-induced hypoglycemia remains a serious life-threatening complication of insulin therapy. Glucagon is a highly effective treatment for hypoglycemia; however, current dosage forms remain under- utilized due to poor patient compliance. High-density, readily soluble, and thermostable solid glucagon formulations applied with painless, application-specific microneedle-patches can treat hypoglycemia in type 1 diabetes patients who are awake or asleep. On-demand patches can prevent or treat mild hypoglycemia during the day, and enzyme-driven hypoglycemia-responsive patches can release glucagon autonomously during the night. These patches have excellent in vitro glucagon stability, loading, and release kinetics and can treat hypoglycemia in diabetic humans and animals. These delivery systems enable new modes of glucagon therapy, thereby expanding the clinical role of glucagon beyond the emergency setting.
Ingestible and/or implantable low power battery and signaling systems are generally provided. Advantageously, the systems and methods described herein may provide, in some embodiments, secure communication such that only authorized users and/or medical professionals can read sensor data and/or send valid commands to a system. Advantageously, the system and methods described herein may provide, in some embodiments, an energy-efficient security protocol to further improve the wireless communication (e.g., of an ingestible and/or implantable article). In some embodiments, the security protocol advantageously provides data encryption to protect sensor and command information and mutual authentication to prevent unauthorized access to both ingestible and external devices.
A61B 5/24 - Détection, mesure ou enregistrement de signaux bioélectriques ou biomagnétiques du corps ou de parties de celui-ci
A61B 1/00 - Instruments pour procéder à l'examen médical de l'intérieur des cavités ou des conduits du corps par inspection visuelle ou photographique, p. ex. endoscopesDispositions pour l'éclairage dans ces instruments
The invention relates to methods and products for generating diverse libraries of genetic material. The products include libraries and constructed nucleic acids as well as kits and databases and systems thereof.
C40B 50/06 - Procédés biochimiques, p. ex. utilisant des enzymes ou des micro-organismes viables entiers
C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
C12N 15/66 - Méthodes générales pour insérer un gène dans un vecteur pour former un vecteur recombinant, utilisant le clivage et la ligatureUtilisation de linkers non fonctionnels ou d'adaptateurs, p. ex. linkers contenant la séquence pour une endonucléase de restriction
C40B 40/06 - Bibliothèques comprenant des nucléotides ou des polynucléotides ou leurs dérivés
C40B 40/08 - Bibliothèques comprenant de l'ARN ou de l'ADN codant des protéines, p. ex. bibliothèques de gènes
G16B 20/00 - TIC spécialement adaptées à la génomique ou protéomique fonctionnelle, p. ex. corrélations génotype-phénotype
G16B 20/20 - Détection d’allèles ou de variantes, p. ex. détection de polymorphisme d’un seul nucléotide
G16B 20/30 - Détection de sites de liaison ou de motifs
G16B 35/00 - TIC spécialement adaptées aux bibliothèques combinatoires in silico d’acides nucléiques, de protéines ou de peptides
G16B 40/00 - TIC spécialement adaptées aux biostatistiquesTIC spécialement adaptées à l’apprentissage automatique ou à l’exploration de données liées à la bio-informatique, p. ex. extraction de connaissances ou détection de motifs
G16B 50/00 - TIC pour la programmation d’outils ou de systèmes de bases de données spécialement adaptées à la bio-informatique
G16B 50/30 - Entreposage de donnéesArchitectures informatiques
Cyclic ruthenium benzylidene initiators useful for the controlled synthesis of functionalized cyclic macromolecules via ring-expansion metathesis polymerization.
C08F 132/04 - Homopolymères de composés cycliques ne contenant pas de radicaux aliphatiques non saturés dans une chaîne latérale et contenant une ou plusieurs liaisons doubles carbone-carbone dans un système carbocyclique ne contenant pas de cycles condensés contenant une seule double liaison carbone-carbone
C07F 15/00 - Composés contenant des éléments des groupes 8, 9, 10 ou 18 du tableau périodique
A method for making a lithium salt film includes heating a substrate, spraying a mixture with a spray nozzle onto the substrate to form a precursor film, and annealing the precursor film to form the lithium salt film. The lithium salt film has a thickness of about 400 nm to about 100 pm. The spray mixture includes a first precursor comprising a lithium ion, a second precursor comprising an anion, and a solvent.
C23C 18/12 - Revêtement chimique par décomposition soit de composés liquides, soit de solutions des composés constituant le revêtement, ne laissant pas de produits de réaction du matériau de la surface dans le revêtementDépôt par contact par décomposition thermique caractérisée par le dépôt sur des matériaux inorganiques, autres que des matériaux métalliques
G01N 33/00 - Recherche ou analyse des matériaux par des méthodes spécifiques non couvertes par les groupes
37.
READILY SOLUBLE AND THERMOSTABLE GLUCAGON FORMULATIONS AND DELIVERY FOR MINI-DOSING AND CLOSED -LOOP PROPHYLACTIC TREATMENT OF HYPOGLYCEMIA
Insulin therapy revolutionized the care of patients with diabetes, yet insulin-induced hypoglycemia remains a serious life-threatening complication of insulin therapy. Glucagon is a highly effective treatment for hypoglycemia; however, current dosage forms remain under-utilized due to poor patient compliance. High-density, readily soluble, and thermostable solid glucagon formulations applied with painless, application-specific microneedle-patches can treat hypoglycemia in type 1 diabetes patients who are awake or asleep. On-demand patches can prevent or treat mild hypoglycemia during the day, and enzyme-driven hypoglycemia-responsive patches can release glucagon autonomously during the night. These patches have excellent in vitro glucagon stability, loading, and release kinetics and can treat hypoglycemia in diabetic humans and animals. These delivery systems enable new modes of glucagon therapy, thereby expanding the clinical role of glucagon beyond the emergency setting.
C12N 9/04 - Oxydoréductases (1.), p. ex. luciférase agissant sur des groupes CHOH comme donneurs, p. ex. oxydase de glucose, déshydrogénase lactique (1.1)
C12N 9/08 - Oxydoréductases (1.), p. ex. luciférase agissant sur le peroxyde d'hydrogène comme accepteur (1.11)
38.
NEURAL NETWORK-BASED DYNAMICAL SYSTEM MODELING FOR CONTRASTIVELY LEARNED CONSERVATION LAWS
Obtain, using at least one hardware processor, data characterizing a physical system governed by a physical conservation law. Apply, using the at least one hardware processor, contrastive learning to the data to automatically capture system invariants of the physical system. Employ, using the at least one hardware processor, a neural projection layer to guarantee that a corresponding dynamic machine learning model preserves the captured system invariants. Optionally, predict performance of the physical system using the corresponding dynamic machine learning model.
Disclosed are systems and methods for adjusting an infusion rate of a drug being delivered to a patient. The method includes extracting a fluid sample from the patient, isolating a drug filtrate by processing the fluid sample within a first time period, and analyzing the drug filtrate for a drug concentration using chromatography system, a mass spectrometry system, or both within a second time period. The method further includes comparing, using a control process, the drug concentration with a target concentration range, and adjusting the infusion rate of the drug to ensure the drug concentration is within the target concentration range.
G16H 20/10 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients
40.
FLUORINATED SULFONAMIDE-BASED ELECTROLYTES FOR NON-LITHIUM BATTERIES THEREOF
Disclosed are compositions, electrolytes, electrochemical cells, and batteries comprising a halogenated sodium salt; a halogenated sulfonate; and a co-solvent.
A non-insulated superconducting magnet and related methods and systems are provided herein. In some aspects, the non-insulated superconducting magnet comprises at least one heating element configured to induce a quench of the non-insulated superconducting magnet by asymmetrically heating the non-insulated superconducting magnet. In some aspects, the non-insulated superconducting magnet comprises at least one cable comprising at least one heating element configured to induce quench of the non-insulated superconducting magnet by heating the non-insulated superconducting magnet. In some aspects, the non-insulated superconducting magnet comprises a first plate having at least one groove arranged in a plurality of turns, and a conductor disposed in the at least one groove, wherein a resistivity of the conductor varies along a length of the conductor.
A mobile physical telemedicine system includes a processing system and at least one robotic manipulator communicatively coupled to the processing system and configured to support and manipulate a body part of a subject. In some embodiments, the system includes a motion capture system communicatively coupled to the processing system and configured to capture a motion of the subject. In some embodiments, the system includes an adjustable therapy bench. In some embodiments, the system includes a base supporting the at least one robotic manipulator, the motion capture system, and the adjustable therapy bench. In some embodiments, the at least one robotic manipulator is configured to be controlled remotely by a clinical provider. In some embodiments, the at least one robotic manipulator is configured to be operated in an autonomous mode.
G16H 20/30 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies ou des activités physiques, p. ex. la physiothérapie, l’acupression ou les exercices
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
G16H 80/00 - TIC spécialement adaptées pour faciliter la communication entre les professionnels de la santé ou les patients, p. ex. pour le diagnostic collaboratif, la thérapie collaborative ou la surveillance collaborative de l’état de santé
43.
Chemical and Physical Sensing with a Reader and RFID Tags
A method of detecting a stimulus can include detecting an output from a radio frequency identification tag including a sensor. A smartphone-based sensing strategy can use chemiresponsive nanomaterials integrated into the circuitry of commercial Near Field Communication tags to achieve non-line-of-sight, portable, and inexpensive detection and discrimination of gas phase chemicals (e.g., ammonia, hydrogen peroxide, cyclohexanone, and water) at part-per-thousand and part-per-million concentrations.
G06K 19/07 - Supports d'enregistrement avec des marques conductrices, des circuits imprimés ou des éléments de circuit à semi-conducteurs, p. ex. cartes d'identité ou cartes de crédit avec des puces à circuit intégré
G01N 27/04 - Recherche ou analyse des matériaux par l'emploi de moyens électriques, électrochimiques ou magnétiques en recherchant l'impédance en recherchant la résistance
G01N 33/00 - Recherche ou analyse des matériaux par des méthodes spécifiques non couvertes par les groupes
G06F 3/01 - Dispositions d'entrée ou dispositions d'entrée et de sortie combinées pour l'interaction entre l'utilisateur et le calculateur
G06K 19/077 - Détails de structure, p. ex. montage de circuits dans le support
G08C 17/02 - Dispositions pour transmettre des signaux caractérisées par l'utilisation d'une voie électrique sans fil utilisant une voie radio
44.
ULTRA-HIGH RESOLUTION MAPPING OF 3D GENOME STRUCTURE USING REGION CAPTURE MICRO-C
A method for identifying nucleic acid regions which interact with each other in genomic DNA, the method including the steps of: (1) crosslinking genomic DNA (including chromatin) in cells; (2) digesting the crosslinked genomic DNA to obtain fragments; (3) fragment end labelling; (4) ligating nucleic acid fragments; (5) obtaining a purified DNA fraction of ligation products including mainly di-nucleosomes; (6) preparing a sequencing library from the DNA fraction of ligation products mainly di-nucleosomes; and (7) performing tiling region capture of a region of interest.
A method for identifying nucleic acid regions which interact with each other in genomic DNA, the method including the steps of: (1) crosslinking genomic DNA (including chromatin) in cells; (2) digesting the crosslinked genomic DNA to obtain fragments; (3) fragment end labelling; (4) ligating nucleic acid fragments; (5) obtaining a purified DNA fraction of ligation products including mainly di-nucleosomes; (6) preparing a sequencing library from the DNA fraction of ligation products mainly di-nucleosomes; and (7) performing tiling region capture of a region of interest.
Selection of processing steps/reagents in the disclosed method provides a significantly improved method when compared to prior methods such as Hi-C, Micro-C, Micro-Capture-C (MCC), and Tiled-Micro-Capture-C (TMCC) in terms of reduction in cost, significantly improved efficiency, with capture of genomic interactions including enhancer-promoter interactions such as microcompartments.
A multi-phase electrolyte film includes a first phase comprising a metal oxide, wherein the metal oxide is amorphous, crystalline, or a glass; and a second phase comprising a lithium salt having a decomposition temperature in air of greater than 200° C. or a lithium halide. The first phase is dispersed in the second phase and has an average particle size of 5 to 200 nanometers. Methods for the manufacture of the electrolyte film are also disclosed.
Provided herein are systems, devices, and methods for carbon capture and storage. A system for carbon capture and storage may comprise a chamber containing an aqueous solution, as well as a cathode and anode immersed in the aqueous solution. The system may further comprise a power supply connected to the cathode and the anode. The power supply may be configured to apply a voltage across the cathode and the anode, resulting in the electrochemical production of minerals as a solid precipitate.
Systems and methods disclose a practical implementation of optimal modulation (OM) for the Complex Additive White Gaussian Noise (CAWGN) channel. At the sender, we map from uniform distributions of data to non-uniform distributions of points in constellations by using a technique inspired by Huffman codes. We replace Gray codes with a bit mapping suited to our constellations, where different points may map to string of bits of different lengths. At the receiver, we perform distribution-aware detection. The differing lengths of bits for modulation points can used as a simple checking mechanism that, when combined with guessing random additive noise decoding (GRAND), yields bit-error-rate (BER) advantages.
The Research Foundation for the State University of New York (USA)
Inventeur(s)
Khaykovich, Boris
Zheng, Guiqiu
Sprouster, David
Abrégé
A system for determining atomic structure and dynamics of salt under certain temperatures as a function of temperature above and below salt melting, contains a quartz tube containing a first end and a second end, and a graphite rod that is located within the quartz tube. The graphite rod contains a hollow center that extends from a top portion of the rod to a location prior to a bottom of the rod, wherein the bottom portion of the rod is enclosed. A sample of salt is located within the hollow center of the graphite rod. A filling material having the characteristics of not reacting to the graphite rod and not changing state with heating of the salt to a melting point of the salt, and wherein the filling material is positioned beneath the graphite rod between the second end of the quartz tube and the bottom of the graphite rod.
G01N 21/31 - CouleurPropriétés spectrales, c.-à-d. comparaison de l'effet du matériau sur la lumière pour plusieurs longueurs d'ondes ou plusieurs bandes de longueurs d'ondes différentes en recherchant l'effet relatif du matériau pour les longueurs d'ondes caractéristiques d'éléments ou de molécules spécifiques, p. ex. spectrométrie d'absorption atomique
G01N 1/44 - Traitement d'échantillons mettant en œuvre un rayonnement, p. ex. de la chaleur
49.
CONTROLLABLE TRANSFORMATION NETWORKS FOR RADIO FREQUENCY POWER CONVERSION
In one aspect, a system for transforming a radio frequency (RF) signal between a source and a load can include: a first port and a second port connected to different ones of the source and the load; a first filter connected to the first port; a second filter connected to the second port, at least one of the first and second filters operable to provide variable reactance using dynamic frequency tuning (DFT); a two-port switching network connected between the first filter and the second filter, the switching network comprising a plurality of switches; and a controller coupled to the switching network and to the source, the controller configured to operate the plurality of switches according to a switching pattern and to dynamically adjust a frequency of the RF signal to provide controllable impedance matching between the first port and the second port.
H02M 1/00 - Détails d'appareils pour transformation
H02M 1/08 - Circuits spécialement adaptés à la production d'une tension de commande pour les dispositifs à semi-conducteurs incorporés dans des convertisseurs statiques
H02M 5/293 - Transformation d'une puissance d'entrée en courant alternatif en une puissance de sortie en courant alternatif, p. ex. pour changement de la tension, pour changement de la fréquence, pour changement du nombre de phases sans transformation intermédiaire en courant continu par convertisseurs statiques utilisant des tubes à décharge avec électrode de commande ou des dispositifs à semi-conducteurs avec électrode de commande utilisant des dispositifs du type triode ou transistor exigeant l'application continue d'un signal de commande utilisant uniquement des dispositifs à semi-conducteurs
H02M 7/5387 - Transformation d'une puissance d'entrée en courant continu en une puissance de sortie en courant alternatif sans possibilité de réversibilité par convertisseurs statiques utilisant des tubes à décharge avec électrode de commande ou des dispositifs à semi-conducteurs avec électrode de commande utilisant des dispositifs du type triode ou transistor exigeant l'application continue d'un signal de commande utilisant uniquement des dispositifs à semi-conducteurs, p. ex. onduleurs à impulsions à un seul commutateur dans une configuration en pont
H03F 1/56 - Modifications des impédances d'entrée ou de sortie, non prévues ailleurs
50.
Sequentially Stacked Multi-Stage Desalination System and Method
A sequentially stacked multi-stage desalination system includes a single pair of electrodes, including an anode and a cathode; at least one ion concentration polarization device; and at least one electrodialysis device coupled with the ion concentration polarization device and configured to receive liquid flow from the ion concentration polarization device. Each ion concentration device and electrodialysis device is positioned between the anode and the cathode.
C02F 1/469 - Traitement de l'eau, des eaux résiduaires ou des eaux d'égout par des procédés électrochimiques par séparation électrochimique, p. ex. par électro-osmose, électrodialyse, électrophorèse
B01D 57/02 - Séparation, autre que la séparation de solides, non entièrement couverte par un seul groupe ou sous-classe, p. ex. par électrophorèse
B01D 61/50 - Empilements du type à plaque et cadre
C02F 103/08 - Eau de mer, p. ex. pour le dessalement
51.
SYSTEM AND METHOD FOR RIGID MOTION CORRECTION IN MAGNETIC RESONANCE IMAGING
A system for rigid motion correction for magnetic resonance imaging (MRI) of a subject includes an input for receiving motion corrupted k-space data for the subject acquired using an MRI system, a motion parameter estimation module coupled to the input and configured to estimate motion parameters based on the motion corrupted k-space data, a motion correction neural network coupled to the input and the motion parameter estimation module and configured to generate motion corrected k-space data based on the motion corrupted k-space data and the estimated motion parameters, and a reconstruction module coupled to the motion correction neural network and configured to generate a motion corrected image from the motion corrected k-space data.
Described herein is an expander comprising a resonator having a resonator chamber and an input port, wherein the input port is configured to be coupled to a fluid source having a first pressure and a first temperature. In some embodiments, the expander comprises a first acoustic driver disposed at the input port of the resonator, wherein in response to pressure applied thereto, the first acoustic driver oscillates between an open state and a closed state to generate an acoustic wave within the resonator chamber. In some embodiments, the first acoustic driver comprises one of: a reed valve, a jet edge valve, a rotary valve, a high-speed computer controlled valve, or a solenoid valve. In some embodiments, in response to pressure applied thereto, the first acoustic driver oscillates between the open state and the closed state at a frequency that substantially matches a resonant frequency of the resonator chamber.
F03G 7/00 - Mécanismes produisant une puissance mécanique, non prévus ailleurs ou utilisant une source d'énergie non prévue ailleurs
F25B 9/14 - Machines, installations ou systèmes à compression dans lesquels le fluide frigorigène est l'air ou un autre gaz à point d'ébullition peu élevé caractérisés par le cycle utilisé, p. ex. cycle de Stirling
F28D 21/00 - Appareils échangeurs de chaleur non couverts par l'un des groupes
53.
REPLACING SYNTHETIC FERTILIZERS BY ENGINEERING CEREAL-ASSOCIATED NITROGEN-FIXING BACTERIA TO RELEASE UREA
Nitrogen is one of the primary nutrients essential to all forms of life. However, only a few plant species can live in a symbiotic relationship with nitrogen-fixing bacteria and nitrogen must first be converted to a form that plants can utilize. Accordingly, aspects of the present disclosure relate to providing nitrogen fixation to cereal plants using genetically engineered bacteria. In some embodiments, genetically engineered bacteria comprise engineered nucleic acids encoding one or more urea metabolism regulators and/or effect the activity of one or more urea metabolism regulators. In some embodiments, the genetically engineered bacterium release more extracellular urea compared to wildtype counterparts. In some embodiments, extracellular urea is ultimately broken down into ammonia and carbon dioxide which are subsequently used by a plant cell to produce amino acids and glucose, respectively.
C12N 9/78 - Hydrolases (3.) agissant sur les liaisons carbone-azote autres que les liaisons peptidiques (3.5)
C12N 9/80 - Hydrolases (3.) agissant sur les liaisons carbone-azote autres que les liaisons peptidiques (3.5) agissant sur les liaisons amides des amides aliphatiques
C12P 3/00 - Préparation d'éléments ou de composés inorganiques à l'exception du dioxyde de carbone
Custom folded 3-dimensional plate lattices are modularly assembled to form structures with single and double curvature for use in structural engineering and robotics applications. The plate lattice structural corrugation uses a building block strategy and incorporates custom modified unit cells based on a Kirigami Expanded Miura pattern. This transformation involves expanding the top and bottom zig-zag crease lines into facets and orienting them in space. The structure of these lattices allows for the design of anisotropies in their flexural stiffness by alternating between the Maxwell criterion on bending-dominated and stretch dominated cells. These anisotropies can have value differences of up to 24 times with the same geometry, making them ideal for robotic morphing applications.
55.
ADDITIVE MANUFACTURING USING BONDING OF VOXELS AND RELATED SYSTEMS, DEVICES, AND ARTICLES
Additive manufacturing using bonding of voxels and related systems, devices, and articles are generally described. Certain embodiments are related to additive manufacturing with microscale resolution using solid-state kinetic bonding of microparticles or microfabricated thin-film voxels.
Exemplary methods, systems, apparatus, and computer programs are disclosed for an unmanned aerial system (UAS) inspection system that includes an unmanned aerial system and analysis system for exterior building envelopes and energy performance evaluation and simulation. The UAS can autonomously and systematically collect data for a building's exterior using a payload comprising (i) nondestructive testing (NDT) sensors configured for imaging (visible, infrared, or more) the building and (ii) one or more multi-spectral sensors (LiDAR, ultrasound, radar, or more). The acquired sensor data are provided to an analysis system comprising computer vision (CV) and signal processing modules configured to analyze the acquired data to i) identify building objects (doors, windows, rooftop units, and others) ii) characterize envelope properties (components, heat resistivity, or others) and 3) identify initial thermal anomalies (thermal bridges, physical defects, or infiltration/exfiltration) in a processing pipeline.
G01J 5/00 - Pyrométrie des radiations, p. ex. thermométrie infrarouge ou optique
G01J 5/10 - Pyrométrie des radiations, p. ex. thermométrie infrarouge ou optique en utilisant des détecteurs électriques de radiations
G05D 1/689 - Interaction avec des charges utiles ou des entités externes dirigeant des charges utiles vers des cibles fixes ou en mouvement
G05D 105/80 - Applications spécifiques des véhicules commandés pour la collecte d’informations, p. ex. recherche universitaire
G06T 7/33 - Détermination des paramètres de transformation pour l'alignement des images, c.-à-d. recalage des images utilisant des procédés basés sur les caractéristiques
G06T 7/73 - Détermination de la position ou de l'orientation des objets ou des caméras utilisant des procédés basés sur les caractéristiques
G06V 10/75 - Organisation de procédés de l’appariement, p. ex. comparaisons simultanées ou séquentielles des caractéristiques d’images ou de vidéosApproches-approximative-fine, p. ex. approches multi-échellesAppariement de motifs d’image ou de vidéoMesures de proximité dans les espaces de caractéristiques utilisant l’analyse de contexteSélection des dictionnaires
G06V 10/764 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant la classification, p. ex. des objets vidéo
An electrical joint includes a conductive member having a first mounting region configured to connect to a first conductor and a second mounting region configured to connect to a second conductor, wherein the first conductor comprises a cable and a superconducting material within the conductive member and configured to conduct a current between the first and second mounting regions. Also described is a method of forming an electrical joint, comprising forming a conductive member having a first mounting region configured to connect to a first conductor and a second mounting region configured to connect to a second conductor, wherein the first conductor comprises a cable and a superconducting material within the conductive member and configured to conduct a current between the first and second mounting regions.
A high capacity current lead (10) comprises components that are electrically coupled using indium joints. The current lead includes a heat exchanger having a portion at room temperature (100) and a portion (200) within a vacuum cryostat. The room-temperature portion is temperature controlled against both overheating and over-cooling. The cryogenic portion (200) of the heat exchanger is electrically coupled to a coolant boiling chamber (300) using indium joints. The boiling chamber (300) has a lid and a base that may be electrically coupled using indium joints, or they may be brazed. The boiling chamber (300) is surrounded by a vacuum lid that may be electrically coupled to the base using indium joints, or brazed. The base is electrically coupled to a superconductor module (400) having high-temperature superconductor (HTS) tapes for conveying current to a device, such as a superconducting electromagnet.
Articles, compositions, and methods describing particles comprising micelles are generally described. In some embodiments, the micelles are configured to absorb pollutants from water and subsequently release the pollutants to a non-aqueous environment.
Multifunctional microelectronics fiber probes can be chronically implanted in tissue of awake-behaving animals for understanding brain-viscera communication. These fiber probes can be made using thermal drawing to make hundreds of meters of flexible fiber that incorporates features such as light sources, electrodes, thermal sensors, and microfluidic channels in a multilayered configuration. The fiber mechanics can be tuned for two distinct device layouts: (1) higher-modulus, flexible brain fibers for implantation into deep-brain; and (2) soft, compliant gut fibers for implantation into the small intestine. Brain fibers can modulate the deep-brain mesolimbic reward pathway. Gut fibers can perform peripheral optogenetic stimulation of vagal afferents from the intestine to stimulate brain reward neurons. Brain and gut fibers can be connected to a control module, for example, with a coiled, stretchable interconnect that is more flexible and stretches more than even soft gut fibers, in dual-organ (gut-brain) implantation.
Knit scaffolds for culturing cells and aiding in the healing of functional tissue are provided. The knit scaffolds have properties aligned with specific tissues for providing optimal tissue growing surfaces including matched biomechanical properties. The scaffolds are made up of knitted material and do not require or utilize a support skeleton for function. Methods of making and using the knit scaffolds are also provided.
Provided herein are oligonucleotides, cell-penetrating peptides, and peptide-oligonucleotide-conjugates. Also provided herein are methods of treating a muscle disease, a viral infection, or a bacterial infection in a subject in need thereof, comprising administering to the subject oligonucleotides, peptides, and peptide-oligonucleotide-conjugates described herein.
C12N 15/113 - Acides nucléiques non codants modulant l'expression des gènes, p. ex. oligonucléotides anti-sens
A61K 47/64 - Conjugués médicament-peptide, médicament-protéine ou médicament-acide polyaminé, c.-à-d. l’agent de modification étant un peptide, une protéine ou un acide polyaminé lié par covalence ou complexé à un agent thérapeutiquement actif
C07K 14/00 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés
63.
SYSTEMS, METHODS, COMPOSITIONS, AND DESIGNS FOR SYNTHESIS AND USE OF EXTREME-WATER-UPTAKE, LEAKAGE-FREE HYGROSCOPIC HYDROGELS
Systems, methods, compositions, and designs for synthesis and use of hygroscopic hydrogels are provided. Hygroscopic hydrogels can be used as scalable and low-cost sorbents for atmospheric water harvesting, dehumidification, passive cooling, and/or thermal energy storage. Sorbent materials can be loaded with salt by soaking the gel in an aqueous solution to form hygroscopic composites. The swelling dynamics of hydrogels in aqueous lithium-chloride solutions, its implications on hydrogel salt loading, as well as the resulting vapor uptake of the synthesized hydrogel-salt composites can be performed. Equilibrating the swelling process of the hydrogels can result in hydrogels with high water uptake and leak-free sorbents that significantly outperform comparative hydrogels.
C08J 3/02 - Production de solutions, dispersions, latex ou gel par d'autres procédés que ceux utilisant les techniques de polymérisation en solution, en émulsion ou en suspension
Disclosed are systems and methods for dynamic occupational satiety stimulation. The system includes a device that includes at least one outer arm, a motor, and a controller that operates the motor to actuate the at least one outer arm. The controller operates the motor to pre-prandially extend the at least one outer arm away from a body of the device, and the controller further operates the motor to post-prandially contract the at least one outer arm.
65.
SYSTEMS, DEVICES, AND METHODS FOR ELECTRODIALYSIS-BASED HOME-SCALE DESALINATION
Systems, devices, and methods for electrodialysis-based home-scale water desalination are disclosed. The system can include an electrodialysis stack having one or more membranes that is in fluid communication with a pump and a valve manifold system for desalinating a feed stream pumped into the electrodialysis stack. Various circuit architectures for the manifold system are possible to obtain the desired recovery ratios that outperform conventional reverse osmosis symptoms. The pump, electrodialysis stack, and valve manifold system, and additional components of the electrodialysis system can be packaged within dimensions of a reverse osmosis cabinet, which can provide for in-home installation and use, while also minimizing points of failure.
The present invention provides polymer compositions for use in cosmetic nail polish compositions. More particularly, the present disclosure relates to the introduction of cleavable conomoner additives into an existing polymer composition to produce a chemically deconstructable composition. Methods and compositions for removing the nail polish composition are also disclosed.
A61K 8/81 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons insaturées carbone-carbone
System and methods related to lyophilization of pharmaceutical products are disclosed. In some embodiments, vials of product are moved through a system using one or more movers which are electromagnetically levitated and moved through the system without making mechanical contact with each other or the system. Load lock chambers may allow a mover to enter from one process region's environment and then be brought to an environment condition of the next process region to allow materials to be passed through conditioning, nucleation, and/or vacuum drying regions prior to finally exit the system to an unloading zone. The movers may then be cleaned or reloaded with vials to begin the process again with a new load of vials.
A61K 9/19 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres lyophilisées
F26B 5/06 - Procédés de séchage d'un matériau solide ou d'objets n'impliquant pas l'utilisation de chaleur par évaporation ou sublimation de l'humidité sous une pression réduite, p. ex. sous vide le procédé impliquant la congélation
H02N 15/00 - Dispositifs de maintien ou de lévitation utilisant l'attraction ou la répulsion magnétique, non prévus ailleurs
The present disclosure provides methods of conducting phytoremediation of soil containing one or more contaminants comprising growing plants in soil treated with nanoparticles, wherein the plants uptake the nanoparticles.
B09C 1/10 - Régénération de sols pollués par des procédés microbiologiques ou utilisant des enzymes
B01J 20/28 - Compositions absorbantes ou adsorbantes solides ou compositions facilitant la filtrationAbsorbants ou adsorbants pour la chromatographieProcédés pour leur préparation, régénération ou réactivation caractérisées par leur forme ou leurs propriétés physiques
B09C 1/08 - Régénération de sols pollués par des procédés chimiques
69.
WINCHES FOR USE WITH INVERTING AND EVERTING ROBOTIC LIMBS
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (USA)
Inventeur(s)
Barhydt, Kentaro
Osele, Obumneme Godson
Asada, Haruhiko, Harry
Abrégé
Disclosed herein is a growing soft robot winch. The design may include a winch which comprises a drum and mandrel (e.g., a cylindrical shaft). The winch may be used to retain and retract a vine robot. The winch may use friction between adjacent portions of the vine robot wound onto the mandrel. One or more clamps configured to grasp the vine robot within a cavity formed in the mandrel may assist in retaining a distal end portion of the vine robot therein during operation. The mandrel may form part of a winch such that the vine robot wound thereon may be held on primarily by friction to apply large tensile loads to the attached vine robot.
F15B 15/10 - Dispositifs actionnés par fluides pour déplacer un organe d'une position à une autreTransmission associée à ces dispositifs caractérisés par la structure de l'ensemble moteur le moteur étant du type à diaphragme
B25J 19/00 - Accessoires adaptés aux manipulateurs, p. ex. pour contrôler, pour observerDispositifs de sécurité combinés avec les manipulateurs ou spécialement conçus pour être utilisés en association avec ces manipulateurs
B25J 21/00 - Enceintes à dispositifs de manipulation intégrés
70.
Method and System for Data-Hiding Within Audio Transmissions
A method for hiding data within cover audio uses a set of sample codebook waveforms that are each assigned a unique representative digit value. A hidden data sequence representing the data is formed from the waveforms by concatenation of the waveforms assigned to the digit values of the data. The sequence is superimposed upon segments of the cover audio at a fractional amplitude. After transmission, the received signal is decompressed if necessary, the hidden data sequence is recovered from the cover audio, and the data is recovered from the hidden data sequence. This may be done by recovering the locations of the codebook waveforms and interpolating the time markers of the locations. The recovered data may be cleaned up by using estimated distances between successive cross-correlations to discard extraneous correlation peaks and sequence recurrence to probabilistically delete overlapping correlation peaks.
G10L 19/018 - Mise en place d’un filigrane audio, c.-à-d. insertion de données inaudibles dans le signal audio
G10L 19/00 - Techniques d'analyse ou de synthèse de la parole ou des signaux audio pour la réduction de la redondance, p. ex. dans les vocodeursCodage ou décodage de la parole ou des signaux audio utilisant les modèles source-filtre ou l’analyse psychoacoustique
Described in several exemplary embodiments are compositions including a targeting moiety effective to target a central nervous system cell and formulations thereof. In certain embodiments, the targeting moiety is composed of one or more n-mer inserts, that can include one or more RGD motifs, and/or one or more P-motifs. Also described in certain example embodiments are vector systems configured to generate polypeptides containing the one or more targeting moieties. Also described herein are methods of generating a targeting moiety effective to target a central nervous system cell and using the compositions containing the targeting moieties described herein, such as to deliver a cargo to a subject and/or treat a central nervous system disease, disorder, or system thereof.
A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiquesThérapie génique
The present disclosure describes functional oligomers or functional polymers. The functional oligomers or functional polymers may contain functional groups, e.g., —OH and/or —CHO. The functional oligomers or functional polymers may be obtained from hydrolyzing certain copolymers and may be soluble in commercially available solvents. The copolymers may be thermosetting polymers. The functional oligomers and functional polymers may be useful for recycling thermosetting polymers and may be useful as starting materials for preparing additional oligomers or polymers.
C08F 232/08 - Copolymères de composés cycliques ne contenant pas de radicaux aliphatiques non saturés dans une chaîne latérale et contenant une ou plusieurs liaisons doubles carbone-carbone dans un système carbocyclique contenant des cycles condensés
C08F 234/02 - Copolymères de composés cycliques ne contenant pas de radicaux aliphatiques non saturés dans une chaîne latérale et contenant une ou plusieurs liaisons doubles carbone-carbone dans un hétérocycle dans un cycle contenant de l'oxygène
73.
RADIATIVELY RECUPERATED REACTOR SYSTEM AND RELATED METHODS, SUCH AS CHEMICAL LOOPING PROCESSES
What is disclosed relates to a novel reactor system design for chemical looping solar fuel production processes incorporating temperature swing between two or more zones, wherein two or more individual reactors are employed, and heat is recuperated between the reactors by means including radiative heat exchange. Each individual reactor comprising the overall system is isolated from other reactors and the external environment for gas exchange purposes, so that the inflow and outflow of chemical species from individual reactors can be controlled. Individual reactors are arranged in the form of a moving train, and heat exchange between a pair of reactors is facilitated by radiative exchange. External heat addition and removal between the system and its environment may be achieved by means including radiative heat exchange with the hot source and convective exchange with the cold source. This may include, in a particular embodiment, the use of solar irradiation. The disclosure also includes procedures for operating such a system.
Systems and methods for providing a configurable handle for assisting a user to perform an activity arc disclosed. A device may include a mobile base, a robotic arm attached to and supported by the mobile base, and a handle attached to the robotic arm. The handle may be configured to be grasped by and support a user during the activity and the robotic arm may be configured to position the handle in a desired pose relative to the user during the activity. The device may be calibrated involving one or more cameras configured to image the user.
B01J 20/22 - Compositions absorbantes ou adsorbantes solides ou compositions facilitant la filtrationAbsorbants ou adsorbants pour la chromatographieProcédés pour leur préparation, régénération ou réactivation contenant une substance organique
B01D 53/02 - Séparation de gaz ou de vapeursRécupération de vapeurs de solvants volatils dans les gazÉpuration chimique ou biologique des gaz résiduaires, p. ex. gaz d'échappement des moteurs à combustion, fumées, vapeurs, gaz de combustion ou aérosols par adsorption, p. ex. chromatographie préparatoire en phase gazeuse
76.
TRACKING THE LEVEL OF ANESTHESIA-MEDIATED UNCONSCIOUSNESS
Systems and methods for controlling anesthetic-mediated unconsciousness in a patient are disclosed. An electroencephalogram (EEG) of a patient under a GABAergic-anesthetic may be recorded using EEG electrodes. Unconsciousness maintained by GABAergic anesthetics, such as propofol, propanidid, and/or sevoflurane, is characterized by slow-delta oscillations (0.3-4 Hz) and alpha oscillations (8-14 Hz) that may be viewed in an electroencephalogram (EEG). An alpha modulation index and a slow modulation index may be computed to characterize the level of unconsciousness of the patient and set a desired level of unconsciousness. The system may automatically or manually adjust the infusion rate of the anesthetic to achieve the desired level of unconsciousness.
A61B 5/374 - Détection de la répartition de fréquence dans les signaux, p. ex. détection des ondes delta, thêta, alpha, bêta ou gamma
A61B 5/291 - Électrodes bioélectriques à cet effet spécialement adaptées à des utilisations particulières pour l’électroencéphalographie [EEG]
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
77.
CORROSION/EROSION SENSOR AND CORRESPONDING OPERATING METHOD
A method of polynucleotide synthesis includes a series of enzymatic reactions for restriction, ligation, and amplification using a machine and system that provide efficient droplet-based reactions. The method enables hierarchical assembly with minimal handling in order to address challenges associated with traditional polynucleotide synthesis methods, such as high cost, limited throughput, long synthesis times, and limited ability to synthesize long sequences.
An antenna comprises first and second substrates with one or more spacers disposed therebetween so as to provide a substantially uniform an air gap between the substrates. Disposed on the first and second substrates are one or more antenna elements and disposed on at least one of the substrates is a feed circuit.
The systems, devices, and methods presented herein use a heart pump to obtain measurements of cardiovascular function. The heart pumps described herein can operate in parallel with and unload the heart. The system can quantify the functioning of the native heart by measuring certain parameters/signals such as pressure or motor current, then calculate and display one or more metrics of cardiovascular function. These metrics, such as left ventricular end diastolic pressure (LVEDP), left ventricular pressure, and contractility, provide valuable information to a user regarding a patient's state of heart function and recovery.
A61B 5/021 - Mesure de la pression dans le cœur ou dans les vaisseaux sanguins
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/02 - Détection, mesure ou enregistrement en vue de l'évaluation du système cardio-vasculaire, p. ex. mesure du pouls, du rythme cardiaque, de la pression sanguine ou du débit sanguin
A61B 5/0205 - Évaluation simultanée de l'état cardio-vasculaire et de l'état d'autres parties du corps, p. ex. de l'état cardiaque et respiratoire
A61B 5/0215 - Mesure de la pression dans le cœur ou dans les vaisseaux sanguins par des moyens introduits dans le corps
A61B 5/024 - Mesure du pouls ou des pulsations cardiaques
A61B 5/029 - Mesure du débit de sang à la sortie du cœur, p. ex. volume éjecté par minute
A61B 5/352 - Détection des crêtes de l'onde R, p. ex. pour la synchronisation d'appareils de diagnosticEstimation de l’intervalle entre crêtes R
A61M 60/178 - Pompes ou dispositifs de pompage implantables, c.-à-d. que le sang est pompé à l’intérieur du corps du patient implantables dans ou sur le cœur, ou autour du cœur prélevant le sang d’un ventricule et renvoyant le sang vers le système artériel par une canule externe au ventricule, p. ex. dispositifs d’assistance pour ventricule gauche ou droit
A61M 60/216 - Pompes pour le sang à déplacement non positif comportant un élément rotatif agissant sur le sang, p. ex. un impulseur
A61M 60/422 - Détails concernant l’entraînement des pompes pour le sang à déplacement non positif la force agissant sur l’élément en contact avec le sang étant électromagnétique, p. ex. en utilisant des pompes à moteur à gaine
A61M 60/531 - Régulation par des données du patient en temps réel par des données de tension artérielle, p. ex. provenant de capteurs de tension
A61M 60/554 - Régulation par des données en temps réel de paramètres fonctionnels de la pompe pour le sang, p. ex. par l’intensité du courant d’un moteur de la tension artérielle
Embodiments utilize a method of making a mold (108a) of additive manufacturing material for use in producing a structural element for a structure. The mold (108a) includes an interior surface (502) having a geometry defined by the additive manufacturing material configured to constrain a composition of matter to be disposed within the geometry of the interior surface at least until the composition of matter sufficiently stabilizes with a shape, based on the geometry, toward becoming the structural element. The mold also includes an exterior surface (503) having a geometry defined by the additive manufacturing material, the geometry being a function of: (i) hydrostatic pressure expected to be exhibited as a combination of at least the composition of matter as constrained by the interior surface, and (ii) properties of the additive manufacturing material between the interior and exterior surfaces.
Methods for designing a prosthetic feet for use by above-knee amputees, and the resulting prosthetic foot designs, are disclosed. The prosthetic foot can be optimized to best replicate hip movement of an able-bodied user for an above-knee amputee that inherently lacks early and mid-stance knee flexion. The replication can be determined by minimizing what is referred to as a hip trajectory error. The resulting prosthetic foot design includes a keel, an elongated forefoot section attached to the keel at an attachment point, the forefoot section having a toe portion anterior to the attachment point, and a heel attached to the forefoot section and positioned posterior to the attachment point. The keel, the forefoot section, and the heel are configured to provide both shock absorption and replication of hip motion of a comparable able-bodied user despite a lack of early-stance knee flexion and mid-stance knee flexion to an above-knee amputee.
84.
REPROGRAMMABLE FANZOR POLYNUCLEOTIDES AND USES THEREOF
Systems, methods and composition for targeting polynucleotides are detailed herein. In particular, engineered DNA-targeting systems comprising novel Fanzor polypeptides and a reprogrammable targeting nucleic acid component and methods and application of use are described.
85.
METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES
The present disclosure provides new prime editor guide RNAs for prime editing, constructs for prime editing, and methods for using same. In addition, the present disclosure provides compositions and methods for conducting prime editing of a target DNA molecule (e.g., a genome) that enables the incorporation of a nucleotide change and/or targeted mutagenesis (e.g., insertion or deletion). The nucleotide change can include a single-nucleotide change (e.g., any transition or any transversion), an insertion of one or more nucleotides, or a deletion of one or more nucleotides. More in particular, the disclosure provides fusion proteins comprising nucleic acid programmable DNA binding proteins (napDNAbp) and a polymerase (e.g., reverse transcriptase), which is guided to a specific DNA sequence by a prime editor RNA (PEgRNA). The prime editor guide RNA comprises an extension arm that provides a DNA synthesis template sequence which encodes a single strand DNA flap, which is homologous to an endogenous DNA sequence, but which contains the desired one or more nucleotide changes and which, following synthesis by the polymerase (e.g., reverse transcriptase), becomes incorporated into the target DNA molecule.
Systems, methods, and compositions for using Interfacial Photopolymerization (IPP) for high-resolution digital processing of polymers are disclosed. In IPP, a polymer film can be formed at an interface between two liquids, each containing a species involved in a polymerization reaction. The two liquids can include a photoinitiator and a monomer that are immiscible and/or reactive such that the film can form at the interface. The polymerization reaction can be controlled by a LED light source, which is focused at a reaction zone located at or near the liquid-liquid interface. The resulting polymer results in a high-resolution, high-throughput AM of thermoplastic polymers that enables on-demand production of objects that exhibit exceptional dimensional quality, mechanical properties, and recyclability characteristics.
B29C 64/124 - Procédés de fabrication additive n’utilisant que des matériaux liquides ou visqueux, p. ex. dépôt d’un cordon continu de matériau visqueux utilisant des couches de liquide à solidification sélective
B33Y 40/00 - Opérations ou équipements auxiliaires, p. ex. pour la manipulation de matériau
B33Y 70/00 - Matériaux spécialement adaptés à la fabrication additive
C08F 2/16 - Polymérisation en milieu non solvant en milieu aqueux
C08F 2/50 - Polymérisation amorcée par énergie ondulatoire ou par rayonnement corpusculaire par la lumière ultraviolette ou visible avec des agents sensibilisants
Hybrid evaporative and radiative cooling panel systems having increased cooling efficiency while minimizing water consumption are provided. The disclosed hybrid systems include a cooling panel that enables the improved cooling and water consumption via a reflector layer which reflects solar radiation, an evaporative and infrared-emitting layer that is solar-transparent and water-rich, and an insulation layer that is vapor-permeable. infrared-transparent. and solar-reflecting. The cooling panel is configured to be in fluid communication with a heat exchanger. The cooling panel is further configured to cool a heat transfer fluid by way of both evaporative cooling and radiative cooling. The cooling panel is also configured such that the heat transfer fluid passes at least one of through or across the cooling panel and flows to the heat exchanger. Various configurations of such panels and panel systems. and methods of implementing the principles associated with the same. are also disclosed.
F25B 25/00 - Machines, installations ou systèmes utilisant une combinaison des principes de fonctionnement compris dans plusieurs des groupes
F24F 5/00 - Systèmes ou appareils de conditionnement d'air non couverts par ou
F25B 19/00 - Machines, installations ou systèmes utilisant l'évaporation d'un frigorigène mais sans récupération de vapeur
F25B 23/00 - Machines, installations ou systèmes ayant un seul principe de fonctionnement non compris dans les groupes , p. ex. utilisant l'effet de radiation sélective
Described are concepts, systems, structures and techniques for metal filling an open channel (12) in a baseplate (19). In embodiments, metal filling of an open baseplate channel is achieved using vacuum pressure impregnation (VPI). In embodiments, a compression plate (14a) is disposed over an open baseplate channel (12) to be filled with a molten metal. In embodiments, gaskets (97) are disposed between the compression plate (14a) and a surface of the baseplate (10) proximate the baseplate channel (12). In embodiments, a channel cap (26) is disposed over the open channel. In embodiments, the channel cap (26) has a solder flow channel (29, 32) provided in a surface thereof. In the embodiments, the solder flow channel (29, 32) has a meandering shape. In embodiments, a solder flow channel (29, 32′) is provided in the compression plate (14a) and/or the baseplate (10). The concepts, systems, structures and techniques described herein are suitable for use in the fabrication of a no-insulation, no-twist (NINT) high temperature superconducting (HTS) magnet.
H01F 6/06 - Bobines, p. ex. dispositions pour l'enroulement, l'isolation, les enveloppes ou les bornes des bobines
H01F 41/04 - Appareils ou procédés spécialement adaptés à la fabrication ou à l'assemblage des aimants, des inductances ou des transformateursAppareils ou procédés spécialement adaptés à la fabrication des matériaux caractérisés par leurs propriétés magnétiques pour la fabrication de noyaux, bobines ou aimants pour la fabrication de bobines
Meta-optic systems are described that include multi-function metasurfaces formed from a plurality of meta-atoms. A multi-function metasurface can exhibit two or more different optical functions for two or more different states of light incident on the metasurface. Different states of light include different polarizations, different wavelengths, and different angles of incidence. Different optical functions include distance sensing, converging, diverging, image formation, and patterned light formation. The multi-function metasurface can selectively impart different phase profiles to an incident beam depending on the incident beam's state of light.
G02B 1/00 - Éléments optiques caractérisés par la substance dont ils sont faitsRevêtements optiques pour éléments optiques
G02F 1/01 - Dispositifs ou dispositions pour la commande de l'intensité, de la couleur, de la phase, de la polarisation ou de la direction de la lumière arrivant d'une source lumineuse indépendante, p. ex. commutation, ouverture de porte ou modulationOptique non linéaire pour la commande de l'intensité, de la phase, de la polarisation ou de la couleur
H04N 13/239 - Générateurs de signaux d’images utilisant des caméras à images stéréoscopiques utilisant deux capteurs d’images 2D dont la position relative est égale ou en correspondance à l’intervalle oculaire
H04N 13/254 - Générateurs de signaux d’images utilisant des caméras à images stéréoscopiques en combinaison avec des sources de rayonnement électromagnétique pour l’éclairage du sujet
H04N 23/958 - Systèmes de photographie numérique, p. ex. systèmes d'imagerie par champ lumineux pour l'imagerie à grande profondeur de champ
90.
EVOLVING RANDOM HETEROPOLYMERS TOWARDS CATALYTICALLY ACTIVE MATERIALS
The present disclosure relates to using monomer-based heteropolymers to create random heteropolymers that act as biomimetic catalysts that can be evolved to mimic activities of different classes of natural enzymes. The random heteropolymers comprise a mixture of heteropolymer sequences wherein a portion of the heteropolymers comprise a catalytically active region similar to that of a naturally occurring enzyme active site.
C07C 29/14 - Préparation de composés comportant des groupes hydroxyle ou O-métal liés à un atome de carbone ne faisant pas partie d'un cycle aromatique à six chaînons par réduction d'un groupe fonctionnel contenant de l'oxygène de groupes contenant C=O, p. ex. —COOH d'un groupe —CHO
B01J 31/06 - Catalyseurs contenant des hydrures, des complexes de coordination ou des composés organiques contenant des composés organiques ou des hydrures métalliques contenant des polymères
C08F 220/18 - Esters des alcools ou des phénols monohydriques des phénols ou des alcools contenant plusieurs atomes de carbone avec l'acide acrylique ou l'acide méthacrylique
A system comprising a processor and a non-transitory computer-readable medium communicatively coupled to the processor is provided. The medium stores instructions configured to cause the processor to perform operations including receiving, from a user, a search request comprising one or more keywords related to a desired item, determining that the user is a participant in a closed-loop recycling program based on a user setting, identifying, based on the determination and the keywords, one or more item results, at least one qualifying result of the one or more item results having a packaging meeting a predetermined level of recyclability, and providing to the user in a prioritized manner, the at least one qualifying result.
Disclosed herein are polymer networks that include di- and tetra-functional cyclobutane mechanophores, where the mechanophores are incorporated into end-linked polymer networks. Methods of preparing such polymers and of using such polymers are also disclosed herein.
Described in several exemplary embodiments are compositions including a targeting moiety effective to target a central nervous system cell and formulations thereof. In certain embodiments, the targeting moiety is composed of one or more n-mer inserts, that can include one or more RGD motifs, and/or one or more P-motifs. Also described in certain example embodiments are vector systems configured to generate polypeptides containing the one or more targeting moieties. Also described herein are methods of generating a targeting moiety effective to target a central nervous system cell and using the compositions containing the targeting moieties described herein, such as to deliver a cargo to a subject and/or treat a central nervous system disease, disorder, or system thereof.
A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiquesThérapie génique
C07K 14/005 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de virus
Recent advances in the understanding of two CRISPR-Cas systems, namely, Type VI (Cas13a-d) and Type III (Type III-A-B), have shown both of them to have the ability to efficiently target RNA. Provided herein are compositions and methods for trans-splicing precursor mRNA using a catalytically-inactive Cas protein (dCas) and a trans-splicing construct comprising a guide RNA, an intron, a splice acceptor, donor RNA, and a poly A tail. The dCas is capable of forming a complex with the guide RNA and directing sequence-specific binding of the complex to a target precursor mRNA for genetic modification and any polypeptides derived thereof. The technology has important potential therapeutic applications such as correcting genetic mutations through exon replacement, insertion of transgenes, and increasing gene expression, and in non-therapeutic applications such as cell- and tissue-specific diagnostics.
Methods of purifying full capsids of recombinant adeno-associated virus vectors (rAAVs) from a solution containing a mixture of full and empty capsids are described. Typically, methods use crystallization reagents and conditions that preferentially crystalize full rAAV capsids over empty rAAV capsids. Specifically, crystallization reagents and conditions that preferentially crystalize full rAAV5 or rAAV8 capsids over their corresponding empty rAAV capsids are described. The resulting crystals containing mostly or exclusively full rAAV capsids are particularly suited for use in gene therapy. Methods of storing and reconstituting the crystals of full rAAV capsids in preparation for administering to a subject in need thereof are also provided.
Compositions are provided that include a lipid nanoparticle (LNP);a self-replicating RNA encoding a gene of interest loaded within the LNP; and an inhibitory nucleic acid, such as a small interfering RNA (siRNA) targeting IFN-α/β receptor l(Ifharl) gene loaded within the LNP, and use of the compositions for generating an immune response.
Computer program products, computer systems, and computer-implemented methods for making and using computational models for prediction of molecular recognition (MR) between a nanomaterial (NM) MR binder and an analyte. Methods for making a computational model involve selecting a candidate NM MR binder and conducting a physical test to determine whether MR occurs between the candidate NM MR binder and an analyte, and correlating features of the candidate NM MR binder with an experimental result obtained from the physical test to produce predictive information for the computational model. Methods for using the computational model involve receiving features of an untested candidate NM MR binder and analyzing the features to produce a prediction score that represents an expected experimental result of a physical test of the untested candidate MR binder and associating the prediction score with the untested candidate MR binder.
G16C 20/10 - Analyse ou conception des réactions, des synthèses ou des procédés chimiques
G06F 30/27 - Optimisation, vérification ou simulation de l’objet conçu utilisant l’apprentissage automatique, p. ex. l’intelligence artificielle, les réseaux neuronaux, les machines à support de vecteur [MSV] ou l’apprentissage d’un modèle
Board of Regents, The University of Texas System (USA)
Imperial College Innovations Limited (Royaume‑Uni)
Massachusetts Institute of Technology (USA)
Inventeur(s)
Hodes, Marc
Bahadur, Vaibhav
Crowdy, Darren G.
Papageorgiou, Demetrios T.
Hatton, Trevor Alan
Abrégé
A carbon-capture device and related processes are disclosed. The devices include substrate surfaces having a textured surfaces and a liquid sorbent contacting the texture surface in either a Cassie-Baxter state, in the case of a texture omniphobic surface or a plurality of re-entrant features or a Wenzel state, in the case of a textured omniphilic surface. The liquid sorbent reversibly captures a chemical species, which can usefully be carbon dioxide. This reversible capture can be exploited to capture and sequester carbon or other chemical species of interest.
B32B 15/08 - Produits stratifiés composés essentiellement de métal comprenant un métal comme seul composant ou comme composant principal d'une couche adjacente à une autre couche d'une substance spécifique de résine synthétique
B01D 53/14 - Séparation de gaz ou de vapeursRécupération de vapeurs de solvants volatils dans les gazÉpuration chimique ou biologique des gaz résiduaires, p. ex. gaz d'échappement des moteurs à combustion, fumées, vapeurs, gaz de combustion ou aérosols par absorption
B32B 3/26 - Produits stratifiés comprenant une couche ayant des discontinuités ou des rugosités externes ou internes, ou une couche de forme non planeProduits stratifiés comprenant une couche ayant des particularités au niveau de sa forme caractérisés par une couche continue dont le périmètre de la section droite a une allure particulièreProduits stratifiés comprenant une couche ayant des discontinuités ou des rugosités externes ou internes, ou une couche de forme non planeProduits stratifiés comprenant une couche ayant des particularités au niveau de sa forme caractérisés par une couche comportant des cavités ou des vides internes
B32B 27/20 - Produits stratifiés composés essentiellement de résine synthétique caractérisée par l'emploi d'additifs particuliers utilisant des charges, des pigments, des agents thixotropiques
B32B 27/32 - Produits stratifiés composés essentiellement de résine synthétique comprenant des polyoléfines
Aspects of the disclosure relate to non-naturally occurring constructs for the activation of Shank3 gene expression, AAV vectors comprising the constructs, and gene therapy methods.
A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiquesThérapie génique
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
A method for operation of AOFP circuits includes accepting data arriving at any phase of a clock cycle, synchronizing the data to a known phase of a subsequent clock cycle, and providing the synchronized data to an AQFP circuit during the known phase of the subsequent clock cycle. The accepting and synchronizing of the data may be performed by a phase synchronizer and/or by a token-passing circuit. An asynchronous AOFP device includes at least one AQFP circuit and an activation phase synchronizer and/or token-passing circuit. The phase synchronizer may comprise a multiplexed array of QFP Buffers that samples each input phase of the clock cycle through a weak constant zero cell and outputs the logical OR of all input clock phases, propagating an input signal on any activation phase to a first phase output of the next activation cycle. The data may be passed from the phase synchronizer to a token-passing circuit, which passes the accepted and synchronized data to the AQFP during the known phase of the subsequent clock cycle. The token-passing circuit may comprise at least one driving QFP circuit that is triggered by the presence of the accepted data and activates at least one variable activation QFP circuit to store the accepted data in a buffer or propagate it to the AQFP circuit during the known phase of the subsequent clock cycle.